financetom
Business
financetom
/
Business
/
Walgreens names Mike Motz as CEO, goes private under Sycamore Partners
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Walgreens names Mike Motz as CEO, goes private under Sycamore Partners
Aug 28, 2025 7:11 AM

(Reuters) -Walgreens on Thursday named retail veteran Mike Motz as chief executive after the U.S. pharmacy chain was taken private by Sycamore Partners, marking a fresh chapter for the company that has been struggling to keep pace with rivals.

The management shake-up follows the completion of Sycamore's acquisition of Walgreens Boots Alliance for roughly $10 billion.

Motz, who was previously CEO of Staples' U.S. retail business, succeeds Tim Wentworth and will steer the pharmacy operator as it shifts its focus back to core retail and pharmacy operations, Walgreens said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boeing taps debt market to raise $10 billion: sources
Boeing taps debt market to raise $10 billion: sources
Apr 29, 2024
April 29 (Reuters) - Boeing ( BA ) on Monday tapped debt markets to raise $10 billion, after the U.S. planemaker burned $3.93 billion in free cash during the first quarter following slowing production of its best-selling jet, sources familiar with the matter said. Boeing's ( BA ) credit rating hovered above junk status last week from rating agencies as...
Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical
Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical
Apr 29, 2024
12:16 PM EDT, 04/29/2024 (MT Newswires) -- Deciphera Pharmaceuticals ( DCPH ) on Monday agreed to be acquired by Japan-based ONO Pharmaceutical through a tender offer in a deal worth roughly $2.4 billion. Under the terms, investors of the US biopharmaceutical company will receive $25.60 per share in cash, representing a premium of about 75% to its closing price on...
Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
Apr 29, 2024
On Monday, Japanese pharma company ONO Pharmaceutical agreed to acquire Deciphera Pharmaceuticals Inc ( DCPH ) for $25.60 per share in cash, for a total equity value of $2.4 billion.  Deciphera brings specialized research and development capabilities in kinase drug discovery, well-established commercial and sales platforms in the United States and Europe, and global clinical development capabilities.  In addition to QINLOCK – Deciphera’s switch-control inhibitor...
Update: Alliance Resource Shares Rise Following Q1 Earnings Beat
Update: Alliance Resource Shares Rise Following Q1 Earnings Beat
Apr 29, 2024
12:19 PM EDT, 04/29/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph) Alliance Resource Partners ( ARLP ) shares rose 11% in recent Monday trading after the company reported Q1 earnings and revenue that topped estimates by analysts. Q1 earnings fell to $1.21 per diluted limited partner unit from $1.45 a year earlier, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved